![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.431, 2003-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
A high price to pay for medicines in Switzerland
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 506, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The cost of pharmaceutical innovation to patients
By Keyhani Salomeh Ross Joseph S
Expert Opinion on Drug Discovery, Vol. 2, Iss. 11, 2007-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
A high price to pay for generic drugs in Canada
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 509, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Comparative Effectiveness Regulations and Pharmaceutical Innovation
By Vernon John A. Golec Joseph H.
PharmacoEconomics, Vol. 28, Iss. 10, 2010-10 ,pp. :